Corrigendum to A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir.: Journal of Clinical Virology 174 (2024) 105711

Affiliations

• ¹ Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, UK. Electronic address: Sheila.lumley@trinity.ox.ac.uk.
• ² The Francis Crick Institute, 1 Midland Road, London, UK.
• ³ Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK.
• ⁴ The Francis Crick Institute, 1 Midland Road, London, UK; Africa Health Research Institute, Durban, SA.
• ⁵ University of KwaZulu Natal, Nelson R Mandela Medical School, Durban, SA.
• ⁶ Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, UK; KEMRI-Wellcome Trust, Kilifi, Kenya.
• ⁷ KEMRI-Wellcome Trust, Kilifi, Kenya.
• ⁸ Nuffield Department of Medicine, University of Oxford, Oxford, UK.
• ⁹ Bodleian Health Care Libraries, University of Oxford, UK.
• ¹⁰ Institut Pasteur, Université Paris Cité, Unité d' Épidémiologie des Maladies Émergentes, Paris, France.
• ¹¹ The Francis Crick Institute, 1 Midland Road, London, UK; Department of Infectious Diseases, University College London Hospitals, London, UK; Division of Infection and Immunity, University College London, Gower Street, London, UK.